SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-180408
Filing Date
2022-06-24
Accepted
2022-06-23 18:51:35
Documents
12
Period of Report
2022-06-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d374126d8k.htm   iXBRL 8-K 39891
  Complete submission text file 0001193125-22-180408.txt   162719

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bhc-20220621.xsd EX-101.SCH 2534
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20220621_lab.xml EX-101.LAB 18035
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20220621_pre.xml EX-101.PRE 11326
6 EXTRACTED XBRL INSTANCE DOCUMENT d374126d8k_htm.xml XML 3444
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 221036621
SIC: 2834 Pharmaceutical Preparations